Fort Washington Investment Advisors Inc. OH Trims Position in HCA Healthcare, Inc. $HCA

Fort Washington Investment Advisors Inc. OH reduced its position in HCA Healthcare, Inc. (NYSE:HCA) by 16.1% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 232,710 shares of the company’s stock after selling 44,650 shares during the quarter. Fort Washington Investment Advisors Inc. OH owned about 0.10% of HCA Healthcare worth $99,181,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Park Place Capital Corp lifted its position in HCA Healthcare by 2,336.0% in the 2nd quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock valued at $474,000 after acquiring an additional 1,168 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of HCA Healthcare by 11.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock valued at $8,796,000 after purchasing an additional 2,698 shares in the last quarter. Swiss National Bank increased its holdings in HCA Healthcare by 4.3% in the 2nd quarter. Swiss National Bank now owns 558,900 shares of the company’s stock worth $214,115,000 after buying an additional 23,100 shares in the last quarter. Cherokee Insurance Co bought a new position in HCA Healthcare during the 2nd quarter valued at about $3,869,000. Finally, Harrell Investment Partners LLC grew its stake in shares of HCA Healthcare by 176.3% in the second quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock worth $695,000 after acquiring an additional 1,158 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Price Performance

HCA opened at $473.79 on Tuesday. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $520.00. The firm has a market capitalization of $108.12 billion, a PE ratio of 18.31, a price-to-earnings-growth ratio of 1.41 and a beta of 1.36. The business’s 50-day moving average is $476.47 and its two-hundred day moving average is $421.52.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping the consensus estimate of $5.64 by $1.32. The firm had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. HCA Healthcare’s revenue was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, December 29th. Investors of record on Monday, December 15th were paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.6%. The ex-dividend date was Monday, December 15th. HCA Healthcare’s payout ratio is 11.13%.

Insiders Place Their Bets

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the sale, the executive vice president owned 3,487 shares in the company, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.30% of the company’s stock.

Analysts Set New Price Targets

Several analysts have issued reports on HCA shares. Zacks Research lowered HCA Healthcare from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 27th. Bank of America increased their target price on shares of HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a report on Monday, October 27th. Weiss Ratings reissued a “buy (b)” rating on shares of HCA Healthcare in a research note on Monday, December 22nd. Sanford C. Bernstein reissued a “market perform” rating and set a $417.00 price target on shares of HCA Healthcare in a report on Monday, October 27th. Finally, Stephens lifted their target price on HCA Healthcare from $450.00 to $500.00 and gave the company an “overweight” rating in a research note on Monday, October 27th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $479.00.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.